the aid library

Filter

4110

National Tuberculosis And Leprosy Programme: Annual Report 2021

Ministry of Health Zambia (2021) CC

Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success. The NTLP is ... more

Progress in the elimination of lymphatic filariasis in the Western Pacific Region: successes and challenges

A. Yajima; Ichimori, K. International Health (2020) C1

The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout ... more

Guidelines for the management of asthma in adults and adolescents: Position statement of the South African Thoracic Society – 2021 update

Lalloo, U.G.; Kalla, I.S.; Abdool-Gaffar, S. et al. African Journal of Thoracic and Critical Care Medicine (2021) CC

sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ... more

Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review

Wright J.E., Werkman M., Dunn J.C. et al Parasites and Vectors (2018) C2

Background: The human helminth infections include ascariasis, trichuriasis, hookworm infections, schistosomiasis, lymphatic filariasis (LF) and onchocerciasis. It is estimated that almost 2 billion people worldwide are infected with helminths. Whilst the WHO treatment guidelines for helminth infecti ... ons are mostly aimed at controlling morbidity, there has been a recent shift with some countries moving towards goals of disease elimination through mass drug administration, especially for LF and onchocerciasis. However, as prevalence is driven lower, treating entire populations may no longer be the most efficient or cost-effective strategy. Instead, it may be beneficial to identify individuals or demographic groups who are persistently infected, often termed as being “predisposed” to infection, and target treatment at them. Methods: The authors searched Embase, MEDLINE, Global Health, and Web of Science for all English language, humanbased papers investigating predisposition to helminth infections published up to October 31st, 2017. The varying definitions used to describe predisposition, and the statistical tests used to determine its presence, are summarised. Evidence for predisposition is presented, stratified by helminth species, and risk factors for predisposition to infection are identified and discussed. Results: In total, 43 papers were identified, summarising results from 34 different studies in 23 countries. Consistent evidence of predisposition to infection with certain species of human helminth was identified. Children were regularly found to experience greater predisposition to Ascaris lumbricoides, Schistosoma mansoni and S. haematobium than adults. Females were found to be more predisposed to A. lumbricoides infection than were males. Household clustering of infection was identified for A. lumbricoides, T. trichiura and S. japonicum. Ascaris lumbricoides and T. trichiura also showed evidence of familial predisposition. Whilst strong evidence for predisposition to hookworm infection was identified, findings with regards to which groups were affected were considerably more varied than for other helminth species. Conclusion: This review has found consistent evidence of predisposition to heavy (and light) infection for certain human helminth species. However, further research is needed to identify reasons for the reported differences between demographic groups. Molecular epidemiological methods associated with whole genome sequencing to determine ‘who infects whom’ may shed more light on the factors generating predisposition. more

Global Tuberculosis Report 2022 Factsheet
recommended

World Health Organization WHO (2022) C_WHO

The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels. The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area ... more

Factsheet: Drug-Resistant Tuberculosis in the Americas

Pan American Health Organisation PAHO (2021) C_WHO

12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region In 2019 the TB case detection gap in the Region was 52 500 cases

European Drug Report 2019: trends and developments.

European Monitoring Centre for Drugs and Drug Addiction European Union (2019) C1

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as ... more

No Time to Wait: Securing the future from drug-resistant infections

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO

UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis. If no action is taken - warns the UN Ad hoc Interagency Coordin ... more

Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs (Russian Version)

World Health Organization (2016) C_WHO

The END TB Strategy Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных нарко� ... more

Xpert MTB/RIF test Rollout and Implementation Plan

National Tuberculosis and Leprosy Programme Ministry of Health and Social Welfare, Tanzania (2016) C1

The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Lepro ... more

What Kind of Statetegic Policy for a Better Taking Care of Tuberculosis in Senegal

Abdoulaye F., M. Bop, A. Kane Journal of Tropical Diseases (2013) CC

HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t ... more

Resource Effective Strategies to Prevent and Treat Cardiovascular Disease

Schwalm, J.; McKee, M.; Huffman, M. et al. Circulation (2016) CC

Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the ... more

Uganda: Revised National Strategic Plan 2015/16 - 2019/20

Ministry of Health, Republic of Uganda (2017) C2

National Tuberculosis and Leprosy Conrol Programme

National Policy on Prevention and Containment of Antimicrobial Resistance

Ministry of Health, Kenya (2017) C1

Zithromax® Mass Drug Administration Trainers Guide

International Trachoma Initiative (2017) CC

More and more countries are completing their epidemiological mapping of trachoma in suspected endemic districts and are preparing to distribute Zithromax® in those districts where the prevalence of “trachomatous inflammation – follicular” (TF) is above 5% among children aged 1-9 years. Mass ... more

Serbia National Drug Report 2017

European Monitoring Centre for Drugs and Drug Addiction; Republic of Serbia Ministry of Health (2017) C2

Albania National Drug Report 2017

European Monitoring Centre for Drugs and Drug Addiction; Instituti Shendetit Public European Monitoring Centre for Drugs and Drug Addiction; Instituti Shendetit Public (2017) C2

Bosnia and Herzegovina - National Drug Situation Report 2017

European Monitoring Centre for Drugs and Drug Addiction (2018) C2

HIV/AIDS strategy for the Republic of Montenegro

The Republic of Montenegro (2019) C2

Accessed: 24.09.2019

Uganda National Communication Strategy for Promoting Rational Use of Medicines

Federal Ministry of Health, Uganda (2009) C1